{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:55:02Z","timestamp":1790564102587,"version":"4.1.0"},"reference-count":40,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["movementdisorders.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Movement Disorders"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Friedreich ataxia (FRDA) is a rare neurodegenerative disorder with heterogenous clinical progression, complicating prognosis and trial design. Neuroimaging offers objective biomarkers of disease progression, yet variability in progression patterns remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study is to identify distinct neurodegenerative progression patterns in FRDA using longitudinal multimodal magnetic resonance imaging (MRI) and to evaluate associations with clinical, demographic, and genetic factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Longitudinal structural and diffusion MRI data from 54 patients with FRDA and 57 controls were analyzed. Annualized progression rates of macrostructural (volumetric) and microstructural (diffusion) features across cerebellum, brainstem, and spinal cord regions were clustered using Gaussian Mixture Models. Following model selection, clusters were evaluated for biological plausibility of longitudinal imaging trajectories, bootstrap and subsampling reproducibility, and consistency of case\u2010control composition. Associations with demographic, genetic, and clinical variables were examined, and Random Forest modeling assessed predictors of cluster membership.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four statistical clusters were identified, three of which represented robust, biologically interpretable progression patterns characterized by predominant microstructural degeneration, predominant macrostructural atrophy, and minimal measurable progression. The microstructure\u2010 and macrostructure\u2010dominant patterns were enriched for FRDA participants, whereas the minimal\u2010progression pattern contained more controls. GAA1 repeat length was the only variable consistently associated with cluster membership, with larger expansions observed in the microstructure\u2010dominant pattern. Disease duration and clinical progression rates did not significantly differentiate progression patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Longitudinal multimodal MRI shows distinct neurodegenerative progression patterns in FRDA that are not fully captured by conventional clinical measures. This data\u2010driven framework provides a basis for investigating imaging\u2010derived disease heterogeneity and its potential relevance to participant stratification in clinical trials. \u00a9 2026 The Author(s).\n                      <jats:italic>Movement Disorders<\/jats:italic>\n                      published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/mds.70551","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:55:32Z","timestamp":1790560532000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodal Magnetic Resonance Imaging and Machine Learning Uncovers Distinct Progression Patterns in Friedreich Ataxia"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3224-4988","authenticated-orcid":false,"given":"Susmita","family":"Saha","sequence":"first","affiliation":[{"name":"School of Psychological Sciences, The Turner Institute for Brain and Mental Health Monash University  Clayton Victoria Australia"},{"name":"School of Translational Medicine Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0718-6760","authenticated-orcid":false,"given":"Nellie","family":"Georgiou\u2010Karistianis","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, The Turner Institute for Brain and Mental Health Monash University  Clayton Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9269-2714","authenticated-orcid":false,"given":"Vivienne","family":"Teo","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, The Turner Institute for Brain and Mental Health Monash University  Clayton Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A.","family":"Corben","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, The Turner Institute for Brain and Mental Health Monash University  Clayton Victoria Australia"},{"name":"Bruce Lefroy Centre for Genetic Health Research Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Department of Paediatrics University of Melbourne  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7013-9329","authenticated-orcid":false,"given":"David J.","family":"Szmulewicz","sequence":"additional","affiliation":[{"name":"Balance Disorders and Ataxia Service Royal Victorian Eye and Ear Hospital  East Melbourne Victoria Australia"},{"name":"Bionics Department University of Melbourne  Melbourne Victoria Australia"},{"name":"NeuroMovement Laboratory Bionics Institute  East Melbourne Victoria Australia"},{"name":"Neurology Department, Alfred Hospital Monash University  Prahran Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2885-5898","authenticated-orcid":false,"given":"Lachlan T.","family":"Strike","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-2419","authenticated-orcid":false,"suffix":"Jr.","given":"Marcondes C.","family":"Fran\u00e7a","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Campinas  Campinas Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-0313","authenticated-orcid":false,"given":"Thiago J.R.","family":"Rezende","sequence":"additional","affiliation":[{"name":"Department of Neurology University of Campinas  Campinas Brazil"},{"name":"Department of Neurosciences, School of Medicine University of S\u00e3o Paulo at Ribeir\u00e3o Preto (USP\u2010RP)  Ribeir\u00e3o Preto Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6843-9592","authenticated-orcid":false,"given":"Ian H.","family":"Harding","sequence":"additional","affiliation":[{"name":"School of Translational Medicine Monash University  Melbourne Victoria Australia"},{"name":"QIMR Berghofer Medical Research Institute  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"issue":"5254","key":"e_1_2_9_2_1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano V","year":"1996","journal-title":"Science"},{"key":"e_1_2_9_3_1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.802496","article-title":"Functional MRI studies in Friedreich's ataxia: a systematic review","volume":"12","author":"Vavla M","year":"2022","journal-title":"Front Neurol"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812448230"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-1002-3"},{"issue":"4","key":"e_1_2_9_6_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41582-025-01065-y","article-title":"A global perspective on research advances and future challenges in Friedreich ataxia","volume":"21","author":"Indelicato E","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200913"},{"issue":"2","key":"e_1_2_9_8_1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12311-011-0316-8","article-title":"Ataxia rating scales\u2014psychometric profiles, natural history and their application in clinical trials","volume":"11","author":"Saute JAM","year":"2012","journal-title":"Cerebellum"},{"issue":"3","key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s12311-023-01543-3","article-title":"Scale for the assessment and rating of ataxia (SARA): development of a training tool and certification program","volume":"23","author":"Grobe\u2010Einsler M","year":"2024","journal-title":"Cerebellum"},{"issue":"4","key":"e_1_2_9_10_1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mds.22912","article-title":"Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design","volume":"25","author":"Friedman LS","year":"2010","journal-title":"Mov Disord"},{"issue":"5","key":"e_1_2_9_11_1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(21)00027-2","article-title":"Progression characteristics of the European Friedreich's ataxia consortium for translational studies (EFACTS): a 4\u2010year cohort study","volume":"20","author":"Reetz K","year":"2021","journal-title":"Lancet Neurol"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678707.2018.1449638"},{"issue":"5","key":"e_1_2_9_13_1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/acn3.52057","article-title":"Evaluating mFARS in pediatric Friedreich's ataxia: insights from the FACHILD study","volume":"11","author":"Rummey C","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27237"},{"issue":"10","key":"e_1_2_9_15_1","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/mds.29934","article-title":"Sensitivity of advanced magnetic resonance imaging to progression over six months in early spinocerebellar ataxia","volume":"39","author":"Rezende TJ","year":"2024","journal-title":"Mov Disord"},{"key":"e_1_2_9_16_1","unstructured":"Commissioner O of the.Focus Area: Biomarkers; FDA [Internet]. 2024 Aug 9 [cited 2026 Feb 5]. Available from:https:\/\/www.fda.gov\/science-research\/focus-areas-regulatory-science-report\/focus-area-biomarkers."},{"key":"e_1_2_9_17_1","unstructured":"Research C for DE and.Medical Imaging and Drug Development; FDA [Internet]. 2020 Jan 31 [cited 2026 Feb 5]. Available from:https:\/\/www.fda.gov\/drugs\/development-resources\/medical-imaging-and-drug-development."},{"key":"e_1_2_9_18_1","unstructured":"Research C for DE and. FDA[Internet]. FDA; 2025 [cited 2026 Feb 5]. Biomarker Qualification Program. Available from:https:\/\/www.fda.gov\/drugs\/drug-development-tool-ddt-qualification-programs\/biomarker-qualification-program"},{"key":"e_1_2_9_19_1","unstructured":"Opinions and letters of support on the qualification of novel methodologies for medicine development|European Medicines Agency (EMA) [Internet];2011. [cited 2026 Feb 5]. Available from:https:\/\/www.ema.europa.eu\/en\/human\u2010regulatory\u2010overview\/research\u2010development\/scientific\u2010advice\u2010protocol\u2010assistance\/opinions\u2010letters\u2010support\u2010qualification\u2010novel\u2010methodologies\u2010medicine\u2010development."},{"issue":"1","key":"e_1_2_9_20_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mds.26436","article-title":"Longitudinal magnetic resonance imaging study shows progressive pyramidal and callosal damage in Friedreich's ataxia","volume":"31","author":"Rezende TJ","year":"2016","journal-title":"Mov Disord"},{"key":"e_1_2_9_21_1","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1007\/s00415-021-10512-x","article-title":"Longitudinal structural brain changes in Friedreich ataxia depend on disease severity: the IMAGE\u2010FRDA study","volume":"268","author":"Selvadurai LP","year":"2021","journal-title":"J Neurol"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26200"},{"issue":"7","key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hbm.24921","article-title":"Multiple mechanisms underpin cerebral and cerebellar white matter deficits in Friedreich ataxia: the IMAGE\u2010FRDA study","volume":"41","author":"Selvadurai LP","year":"2020","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.29261","article-title":"Progressive spinal cord degeneration in Friedreich's ataxia: results from ENIGMA\u2010ataxia","volume":"38","author":"Rezende TJ","year":"2023","journal-title":"Mov Disord"},{"issue":"4","key":"e_1_2_9_25_1","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad196","article-title":"Brain MRI detects early\u2010stage alterations and disease progression in Friedreich ataxia","volume":"5","author":"Adanyeguh IM","year":"2023","journal-title":"Brain Commun"},{"issue":"5","key":"e_1_2_9_26_1","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac246","article-title":"Spinal cord magnetic resonance imaging and spectroscopy detect early\u2010stage alterations and disease progression in Friedreich ataxia","volume":"4","author":"Joers JM","year":"2022","journal-title":"Brain Commun"},{"issue":"2","key":"e_1_2_9_27_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jon.12270","article-title":"Regional cerebral disease progression in Friedreich's ataxia: a longitudinal diffusion tensor imaging study","volume":"26","author":"Mascalchi M","year":"2016","journal-title":"J Neuroimaging"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12317"},{"issue":"16","key":"e_1_2_9_29_1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich's ataxia","volume":"335","author":"D\u00fcrr A","year":"1996","journal-title":"N Engl J Med"},{"issue":"3","key":"e_1_2_9_30_1","first-page":"554","article-title":"The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia","volume":"59","author":"Filla A","year":"1996","journal-title":"Am J Hum Genet"},{"issue":"11","key":"e_1_2_9_31_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116297","article-title":"Neuroinflammation in Friedreich's ataxia","volume":"23","author":"Apolloni S","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"e_1_2_9_32_1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mds.28825","article-title":"Neuroinflammation in the cerebellum and brainstem in Friedreich ataxia: an [18F]\u2010FEMPA PET study","volume":"37","author":"Khan W","year":"2022","journal-title":"Mov Disord"},{"issue":"11","key":"e_1_2_9_33_1","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/01.wnl.0000218155.46739.90","article-title":"Measuring Friedreich ataxia: complementary features of examination and performance measures","volume":"66","author":"Lynch D","year":"2006","journal-title":"Neurology"},{"issue":"458","key":"e_1_2_9_34_1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1198\/016214502760047131","article-title":"Model\u2010based clustering, discriminant analysis, and density estimation","volume":"97","author":"Fraley C","year":"2002","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"e_1_2_9_35_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1034\/j.1600-0404.2003.00190.x","article-title":"Expanded GAA repeats and clinical variation in Friedreich's ataxia","volume":"109","author":"Mateo I","year":"2004","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"e_1_2_9_36_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mds.26382","article-title":"Delayed\u2010onset Friedreich's ataxia revisited","volume":"31","author":"Lecocq C","year":"2016","journal-title":"Mov Disord"},{"issue":"9","key":"e_1_2_9_37_1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/acn3.332","article-title":"Progression of Friedreich ataxia: quantitative characterization over 5\u2009years","volume":"3","author":"Patel M","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"e_1_2_9_38_1","doi-asserted-by":"crossref","DOI":"10.1002\/0471721182","volume-title":"Finite mixture models","author":"McLachlan G","year":"2000"},{"issue":"1","key":"e_1_2_9_39_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13040-025-00430-3","article-title":"Feature graphs for interpretable unsupervised tree ensembles: centrality, interaction, and application in disease subtyping","volume":"18","author":"Sirocchi C","year":"2025","journal-title":"BioData Min"},{"issue":"8","key":"e_1_2_9_40_1","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1002\/hbm.23655","article-title":"Structural signature of classical versus late\u2010onset friedreich's ataxia by multimodality brain M RI","volume":"38","author":"Rezende TJR","year":"2017","journal-title":"Hum Brain Mapp"},{"key":"e_1_2_9_41_1","doi-asserted-by":"crossref","DOI":"10.3389\/fncom.2023.1243092","article-title":"Clustering and disease subtyping in neuroscience, toward better methodological adaptations","volume":"17","author":"Poulakis K","year":"2023","journal-title":"Front Comput Neurosci"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.70551","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mds.70551","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.70551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:55:37Z","timestamp":1790560537000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.70551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":40,"alternative-id":["10.1002\/mds.70551"],"URL":"https:\/\/doi.org\/10.1002\/mds.70551","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"2026-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"mds.70551"}}